| Particulars |
| Company Name |
Marksans Pharma Ltd |
| Face Value |
1 |
| BSE Code |
524404 |
| Year End |
202603 |
| Full Year |
| Equity (Rs in Cr.) |
45.32 |
| B.V. Rs |
36.50 |
| Sales Rs in Cr. |
1,341.48 |
| NP Rs in Cr. |
300.70 |
| NP Var% |
60.00 |
| Div% |
90.00 |
| CPS Rs |
7.40 |
| EPS Rs |
6.60 |
| Traded Value(Rs in Lakhs) |
295.31 |
| 52 Week High |
267.00 |
| 52 Week Low |
156.00 |
| Price BSE |
256.00 |
| Price NSE |
256.00 |
| Market Capital(Rs in Cr.) |
11,605.52 |
| P/C Ratio |
34.60 |
| P/E Ratio |
38.60 |
| Price Vs.BV |
7.01 |
| Latest Quarter |
| Year End |
202603 |
| Sales Rs in Cr. |
361.57 |
| NP Rs in Cr. |
91.92 |
| NP Var % |
145.00 |
| Trailing Twelve Months |
| Year End |
202603 |
| Sales |
1,029.71 |
| OPM |
16.45 |
| NP |
153.50 |
| NP Var% |
60.15 |
| EPS |
6.64 |
| PE |
38.57 |
|